Gland Pharma Q3 Profit Rises 7% to Rs 205 Crore
Gland Pharma's consolidated profit after tax for Q3 FY25 increased by 7% to Rs 205 crore, while revenue declined to Rs 1,384 crore.
New Delhi, Feb 3 (PTI) Gland Pharma on Monday said its consolidated profit after tax increased 7 per cent to Rs 205 crore for the third quarter ended December 31, 2024.
The company had reported a profit after tax of Rs 192 crore for the October-December period of last fiscal.
Revenue from operations however declined to Rs 1,384 crore from Rs 1,545 crore in the year-ago period, Gland Pharma said in a statement.
"We remain focused on driving long-term value creation through strategic partnerships, innovation, and continued investments in new products and technologies," Gland Pharma Executive Chairman Srinivas Sadu said.
Shares of Gland Pharma on Monday declined 0.56 per cent to Rs 1,520.20 apiece on BSE.
The company had reported a profit after tax of Rs 192 crore for the October-December period of last fiscal.
Revenue from operations however declined to Rs 1,384 crore from Rs 1,545 crore in the year-ago period, Gland Pharma said in a statement.
"We remain focused on driving long-term value creation through strategic partnerships, innovation, and continued investments in new products and technologies," Gland Pharma Executive Chairman Srinivas Sadu said.
Shares of Gland Pharma on Monday declined 0.56 per cent to Rs 1,520.20 apiece on BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.04 ( -1.68)
- 102363129
- Srestha Finvest
- 0.51 ( -3.77)
- 22605309
- GMR Airports
- 76.30 (+ 0.83)
- 19768792
- Bajaj HindusthanSuga
- 19.57 ( -2.59)
- 15088109
- G G Engineering
- 0.90 ( -3.23)
- 13176176
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback